ACTR3C
gene geneOn this page
Also known as ARP11
Summary
ACTR3C (actin related protein 3C, HGNC:37282) is a protein-coding gene on chromosome 7q36.1, encoding Actin-related protein 3C (Q9C0K3). May play a role in the suppression of metastatic potential in lung adenoma carcinoma cells.
Predicted to enable ATP binding activity and actin binding activity. Predicted to contribute to actin filament binding activity. Located in extracellular exosome.
Source: NCBI Gene 653857 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 45 total — 2 pathogenic
- MANE Select transcript:
NM_001164458
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37282 |
| Approved symbol | ACTR3C |
| Name | actin related protein 3C |
| Location | 7q36.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ARP11 |
| Ensembl gene | ENSG00000106526 |
| Ensembl biotype | protein_coding |
| Entrez | 653857 |
Gene structure
Transcript identifiers
Ensembl transcripts: 25 — 25 protein_coding
ENST00000252071, ENST00000477367, ENST00000477871, ENST00000478393, ENST00000539352, ENST00000683684, ENST00000865059, ENST00000865060, ENST00000865061, ENST00000865062, ENST00000865063, ENST00000865064, ENST00000865065, ENST00000865066, ENST00000865067, ENST00000865068, ENST00000865069, ENST00000865070, ENST00000916821, ENST00000944427, ENST00000944428, ENST00000944429, ENST00000944430, ENST00000944431, ENST00000944432
RefSeq mRNA: 2 — MANE Select: NM_001164458
NM_001164458, NM_001164459
CCDS: CCDS47744
Canonical transcript exons
ENST00000683684 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001403670 | 150248948 | 150249054 |
| ENSE00002468905 | 150286367 | 150286540 |
| ENSE00002491228 | 150284753 | 150284845 |
| ENSE00002512088 | 150289450 | 150289593 |
| ENSE00003665482 | 150295252 | 150295347 |
| ENSE00003786250 | 150293312 | 150293419 |
| ENSE00003918085 | 150323469 | 150323545 |
| ENSE00003918770 | 150247212 | 150247569 |
Expression profiles
Bgee: expression breadth ubiquitous, 173 present calls, max score 85.11.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.2429 / max 60.4568, expressed in 921 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 86769 | 2.0879 | 736 |
| 86770 | 0.5533 | 262 |
| 86768 | 0.3971 | 207 |
| 86771 | 0.1591 | 73 |
| 86767 | 0.0311 | 14 |
| 204998 | 0.0142 | 5 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 85.11 | gold quality |
| liver | UBERON:0002107 | 81.74 | gold quality |
| islet of Langerhans | UBERON:0000006 | 81.58 | gold quality |
| body of pancreas | UBERON:0001150 | 81.41 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 81.22 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 80.94 | gold quality |
| right adrenal gland | UBERON:0001233 | 80.56 | gold quality |
| pancreas | UBERON:0001264 | 80.37 | gold quality |
| left adrenal gland | UBERON:0001234 | 80.26 | gold quality |
| metanephros cortex | UBERON:0010533 | 79.78 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 79.61 | gold quality |
| adrenal cortex | UBERON:0001235 | 79.53 | gold quality |
| adrenal gland | UBERON:0002369 | 79.26 | gold quality |
| kidney epithelium | UBERON:0004819 | 78.87 | gold quality |
| rectum | UBERON:0001052 | 77.74 | gold quality |
| bone marrow cell | CL:0002092 | 77.09 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.01 | gold quality |
| esophagus mucosa | UBERON:0002469 | 75.28 | gold quality |
| kidney | UBERON:0002113 | 75.22 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 75.12 | gold quality |
| adrenal tissue | UBERON:0018303 | 74.94 | gold quality |
| cortex of kidney | UBERON:0001225 | 74.08 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 73.94 | gold quality |
| gall bladder | UBERON:0002110 | 73.36 | gold quality |
| oviduct epithelium | UBERON:0004804 | 73.18 | gold quality |
| adenohypophysis | UBERON:0002196 | 72.90 | gold quality |
| body of stomach | UBERON:0001161 | 72.45 | gold quality |
| pituitary gland | UBERON:0000007 | 72.28 | gold quality |
| minor salivary gland | UBERON:0001830 | 71.87 | gold quality |
| colonic epithelium | UBERON:0000397 | 71.83 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.33 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
41 targeting ACTR3C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-216A-5P | 99.50 | 68.02 | 1288 |
| HSA-MIR-7849-3P | 99.47 | 68.17 | 1224 |
| HSA-MIR-122B-5P | 99.46 | 70.81 | 1457 |
| HSA-MIR-372-5P | 99.41 | 69.11 | 2299 |
| HSA-MIR-5695 | 99.41 | 67.48 | 1047 |
| HSA-MIR-6731-5P | 99.28 | 67.42 | 2375 |
| HSA-MIR-8085 | 99.28 | 67.56 | 2362 |
| HSA-MIR-4721 | 99.26 | 66.05 | 818 |
| HSA-MIR-3925-5P | 99.21 | 67.90 | 1466 |
| HSA-MIR-4758-3P | 99.12 | 63.96 | 869 |
| HSA-MIR-10524-5P | 99.05 | 66.08 | 963 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | actr3b | ENSDARG00000008790 |
| mus_musculus | Actr3b | ENSMUSG00000056367 |
| rattus_norvegicus | Actr3b | ENSRNOG00000031855 |
Paralogs (26): ACTR6 (ENSG00000075089), ACTB (ENSG00000075624), ACTL6B (ENSG00000077080), ACTR5 (ENSG00000101442), ACTA2 (ENSG00000107796), ACTR8 (ENSG00000113812), ACTR1B (ENSG00000115073), ACTR3 (ENSG00000115091), ACTL8 (ENSG00000117148), ACTRT1 (ENSG00000123165), ACTR10 (ENSG00000131966), ACTR3B (ENSG00000133627), ACTL6A (ENSG00000136518), ACTR2 (ENSG00000138071), ACTR1A (ENSG00000138107), ACTA1 (ENSG00000143632), ACTL7B (ENSG00000148156), ACTC1 (ENSG00000159251), ACTG2 (ENSG00000163017), ACTBL2 (ENSG00000169067), ACTRT2 (ENSG00000169717), ACTL9 (ENSG00000181786), ACTG1 (ENSG00000184009), ACTRT3 (ENSG00000184378), ACTL7A (ENSG00000187003), ACTL10 (ENSG00000288649)
Protein
Protein identifiers
Actin-related protein 3C — Q9C0K3 (reviewed: Q9C0K3)
Alternative names: Actin-related protein 11
All UniProt accessions (5): Q9C0K3, A0A0A0MTI9, C9IZN3, C9J580, H7C4J1
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in the suppression of metastatic potential in lung adenoma carcinoma cells.
Tissue specificity. Expressed in kidney, stomach, spleen, bone marrow, uterus, testis, placenta, skeletal muscle, mammary gland, lung, fetal liver, and fetal kidney, but not detected in small intestine, brain, and thymus. Expressed in low-metastatic lung adenocarcinoma cells but not in high-metastatic ones.
Similarity. Belongs to the actin family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9C0K3-1 | 1 | yes |
| Q9C0K3-2 | 2 |
RefSeq proteins (2): NP_001157930, NP_001157931 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004000 | Actin | Family |
| IPR043129 | ATPase_NBD | Homologous_superfamily |
Pfam: PF00022
UniProt features (4 total): signal peptide 1, chain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9C0K3-F1 | 87.32 | 0.78 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 50 (showing top):
GOMF_ACTIN_BINDING, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, GOMF_CYTOSKELETAL_PROTEIN_BINDING, GOMF_ADENYL_NUCLEOTIDE_BINDING, GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN, ATF6_TARGET_GENES, FOXJ2_TARGET_GENES, FOXN3_TARGET_GENES, H1_6_TARGET_GENES, HOXB4_TARGET_GENES, HOXC6_TARGET_GENES, MAFG_TARGET_GENES, MEF2D_TARGET_GENES, NFE2L1_TARGET_GENES, NKX2_3_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (4): actin binding (GO:0003779), ATP binding (GO:0005524), nucleotide binding (GO:0000166), actin filament binding (GO:0051015)
GO Cellular Component (1): extracellular exosome (GO:0070062)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoskeletal protein binding | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| actin binding | 1 |
| protein-containing complex binding | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
2027 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ACTR3C | ACTR2 | P61160 | 976 |
| ACTR3C | DCTN2 | Q13561 | 912 |
| ACTR3C | DCTN4 | Q9UJW0 | 864 |
| ACTR3C | DCTN5 | Q9BTE1 | 858 |
| ACTR3C | TPPP | O94811 | 847 |
| ACTR3C | CAPZA2 | P47755 | 822 |
| ACTR3C | CAPZA1 | P52907 | 808 |
| ACTR3C | DCTN6 | O00399 | 803 |
| ACTR3C | DCTN1 | Q14203 | 799 |
| ACTR3C | ARPC2 | O15144 | 712 |
| ACTR3C | ARPC5 | O15511 | 706 |
| ACTR3C | ARPC3 | O15145 | 686 |
| ACTR3C | ACTB | P02570 | 678 |
| ACTR3C | WAS | P42768 | 588 |
| ACTR3C | LRRC61 | Q9BV99 | 584 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| STN1 | SMCO3 | psi-mi:“MI:0914”(association) | 0.530 |
| ITGB8 | GET1 | psi-mi:“MI:0914”(association) | 0.530 |
| DUSP21 | A2ML1 | psi-mi:“MI:0914”(association) | 0.350 |
| DND1 | ATXN3 | psi-mi:“MI:0914”(association) | 0.350 |
| MALL | GPR89A | psi-mi:“MI:0914”(association) | 0.350 |
| HCRTR2 | FADS1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (12): ACTR3C (Affinity Capture-MS), ACTR3C (Affinity Capture-MS), ACTR3C (Affinity Capture-MS), ACTR3C (Affinity Capture-MS), ACTR3C (Affinity Capture-MS), ACTR3C (Affinity Capture-MS), ACTR3C (Affinity Capture-RNA), ACTR3C (Affinity Capture-MS), ACTR3C (Affinity Capture-MS), ACTR3C (Affinity Capture-MS), ACTR3C (Affinity Capture-MS), ACTR3C (Affinity Capture-MS)
ESM2 similar proteins: A0A1L8EV45, C9WPN6, F1QGW6, F6RQL9, O73723, O77676, P00516, P0C605, P20461, P23258, P23330, P31321, P32392, P35250, P41091, P53033, P61157, P61158, P62482, P62483, P81795, P83887, P83888, Q05B83, Q0VCD2, Q13126, Q13303, Q13976, Q27955, Q2KHU8, Q2KJ81, Q2VIR3, Q32KM1, Q4V7C7, Q5R797, Q5R8R1, Q5ZHS1, Q5ZMS3, Q641P0, Q641W4
Diamond homologs: A0A1L8EV45, A2BDB0, A2X6S3, O16808, O17320, O18840, O73723, P02576, P02578, P04752, P04829, P07829, P0DM41, P0DM42, P10984, P10986, P10988, P10990, P12716, P13363, P17126, P17128, P22132, P26183, P27131, P30162, P30163, P32390, P32392, P35432, P41112, P41339, P42528, P43239, P45886, P47117, P53458, P53461, P53468, P53470
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 35 |
| Likely benign | 0 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3391897 | GRCh37/hg19 7q31.32-36.1(chr7:122190535-149944340)x1 | Pathogenic |
| 57185 | GRCh38/hg38 7q35-36.1(chr7:147345844-150426340)x1 | Pathogenic |
SpliceAI
2316 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:150284842:CAAA:C | acceptor_gain | 1.0000 |
| 7:150284846:C:CC | acceptor_gain | 1.0000 |
| 7:150284851:T:C | acceptor_gain | 1.0000 |
| 7:150284851:T:TC | acceptor_gain | 1.0000 |
| 7:150284853:G:C | acceptor_gain | 1.0000 |
| 7:150284853:G:GC | acceptor_gain | 1.0000 |
| 7:150284855:A:AC | acceptor_gain | 1.0000 |
| 7:150284855:A:C | acceptor_gain | 1.0000 |
| 7:150284859:CAA:C | acceptor_gain | 1.0000 |
| 7:150284860:A:T | acceptor_gain | 1.0000 |
| 7:150284861:A:AC | acceptor_gain | 1.0000 |
| 7:150284861:A:C | acceptor_gain | 1.0000 |
| 7:150284863:A:C | acceptor_gain | 1.0000 |
| 7:150286361:CCTTA:C | donor_loss | 1.0000 |
| 7:150286362:CTTA:C | donor_loss | 1.0000 |
| 7:150286363:TTA:T | donor_loss | 1.0000 |
| 7:150286364:TA:T | donor_loss | 1.0000 |
| 7:150286365:A:AT | donor_loss | 1.0000 |
| 7:150286365:ACCT:A | donor_gain | 1.0000 |
| 7:150286366:C:CG | donor_loss | 1.0000 |
| 7:150286366:CCT:C | donor_gain | 1.0000 |
| 7:150286366:CCTC:C | donor_gain | 1.0000 |
| 7:150295246:TTTTA:T | donor_loss | 1.0000 |
| 7:150295247:TTTA:T | donor_loss | 1.0000 |
| 7:150295248:TTA:T | donor_loss | 1.0000 |
| 7:150295249:TA:T | donor_loss | 1.0000 |
| 7:150295250:A:AG | donor_loss | 1.0000 |
| 7:150295251:CCTG:C | donor_loss | 1.0000 |
| 7:150295344:CTGT:C | acceptor_gain | 1.0000 |
| 7:150295346:GTCT:G | acceptor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000002215 (7:150127353 C>G), RS1000014160 (7:150032693 C>A), RS1000027285 (7:150278144 G>A,T), RS1000028133 (7:150230241 A>C), RS1000030712 (7:150174702 C>A,G), RS1000045177 (7:150032538 C>T), RS1000049177 (7:149981999 A>G), RS1000051010 (7:150082634 C>A), RS1000052030 (7:149882416 C>T), RS1000063409 (7:150324086 G>T), RS1000072646 (7:149886488 C>T), RS1000119052 (7:150084128 T>G), RS1000120777 (7:149937584 C>T), RS1000135859 (7:149989072 C>T), RS1000142761 (7:150277993 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004389_3 | Circulating chemerin levels | 8.000000e-14 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004573 | chemerin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation | 2 |
| Cadmium Chloride | decreases expression, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| cupric oxide | decreases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.